Regulation of T Lymphocyte Metabolism Kenneth A
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Evidence for Extensive Heterotrophic Metabolism, Antioxidant Action, and Associated Regulatory Events During Winter Hardening In
Collakova et al. BMC Plant Biology 2013, 13:72 http://www.biomedcentral.com/1471-2229/13/72 RESEARCH ARTICLE Open Access Evidence for extensive heterotrophic metabolism, antioxidant action, and associated regulatory events during winter hardening in Sitka spruce Eva Collakova1, Curtis Klumas2, Haktan Suren2,3,ElijahMyers2,LenwoodSHeath4, Jason A Holliday3 and Ruth Grene1* Abstract Background: Cold acclimation in woody perennials is a metabolically intensive process, but coincides with environmental conditions that are not conducive to the generation of energy through photosynthesis. While the negative effects of low temperatures on the photosynthetic apparatus during winter have been well studied, less is known about how this is reflected at the level of gene and metabolite expression, nor how the plant generates primary metabolites needed for adaptive processes during autumn. Results: The MapMan tool revealed enrichment of the expression of genes related to mitochondrial function, antioxidant and associated regulatory activity, while changes in metabolite levels over the time course were consistent with the gene expression patterns observed. Genes related to thylakoid function were down-regulated as expected, with the exception of plastid targeted specific antioxidant gene products such as thylakoid-bound ascorbate peroxidase, components of the reactive oxygen species scavenging cycle, and the plastid terminal oxidase. In contrast, the conventional and alternative mitochondrial electron transport chains, the tricarboxylic acid cycle, and redox-associated proteins providing reactive oxygen species scavenging generated by electron transport chains functioning at low temperatures were all active. Conclusions: A regulatory mechanism linking thylakoid-bound ascorbate peroxidase action with “chloroplast dormancy” is proposed. Most importantly, the energy and substrates required for the substantial metabolic remodeling that is a hallmark of freezing acclimation could be provided by heterotrophic metabolism. -
Direct Interaction Between Hnrnp-M and CDC5L/PLRG1 Proteins Affects Alternative Splice Site Choice
Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice David Llères, Marco Denegri, Marco Biggiogera, Paul Ajuh, Angus Lamond To cite this version: David Llères, Marco Denegri, Marco Biggiogera, Paul Ajuh, Angus Lamond. Direct interaction be- tween hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. EMBO Reports, EMBO Press, 2010, 11 (6), pp.445 - 451. 10.1038/embor.2010.64. hal-03027049 HAL Id: hal-03027049 https://hal.archives-ouvertes.fr/hal-03027049 Submitted on 26 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. scientificscientificreport report Direct interaction between hnRNP-M and CDC5L/ PLRG1 proteins affects alternative splice site choice David Lle`res1*, Marco Denegri1*w,MarcoBiggiogera2,PaulAjuh1z & Angus I. Lamond1+ 1Wellcome Trust Centre for Gene Regulation & Expression, College of Life Sciences, University of Dundee, Dundee, UK, and 2LaboratoriodiBiologiaCellulareandCentrodiStudioperl’IstochimicadelCNR,DipartimentodiBiologiaAnimale, Universita’ di Pavia, Pavia, Italy Heterogeneous nuclear ribonucleoprotein-M (hnRNP-M) is an and affect the fate of heterogeneous nuclear RNAs by influencing their abundant nuclear protein that binds to pre-mRNA and is a structure and/or by facilitating or hindering the interaction of their component of the spliceosome complex. -
The Survival Kinases Akt and Pim As Potential Pharmacological Targets
The survival kinases Akt and Pim as potential pharmacological targets Ravi Amaravadi, Craig B. Thompson J Clin Invest. 2005;115(10):2618-2624. https://doi.org/10.1172/JCI26273. Review Series The Akt and Pim kinases are cytoplasmic serine/threonine kinases that control programmed cell death by phosphorylating substrates that regulate both apoptosis and cellular metabolism. The PI3K-dependent activation of the Akt kinases and the JAK/STAT–dependent induction of the Pim kinases are examples of partially overlapping survival kinase pathways. Pharmacological manipulation of such kinases could have a major impact on the treatment of a wide variety of human diseases including cancer, inflammatory disorders, and ischemic diseases. Find the latest version: https://jci.me/26273/pdf Review series The survival kinases Akt and Pim as potential pharmacological targets Ravi Amaravadi and Craig B. Thompson Abramson Family Cancer Research Institute, Department of Cancer Biology and Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. The Akt and Pim kinases are cytoplasmic serine/threonine kinases that control programmed cell death by phos- phorylating substrates that regulate both apoptosis and cellular metabolism. The PI3K-dependent activation of the Akt kinases and the JAK/STAT–dependent induction of the Pim kinases are examples of partially overlapping sur- vival kinase pathways. Pharmacological manipulation of such kinases could have a major impact on the treatment of a wide variety of human diseases including cancer, inflammatory disorders, and ischemic diseases. Introduction allow myc to act as an oncogene, leading to a malignant phe- There is increasing evidence that serine/threonine kinases exist notype. While deficiency in the tumor suppressor gene p53 and that directly regulate cell survival. -
Glycolysis and Gluconeogenesis Are Regulated Independently
Substrate cycles in glucose metabolism Glycolysis and gluconeogenesis! are regulated independently (the ΔG! values shown are for the corresponding! reactions in liver; in kJ/mol). All six! reactions are exergonic.! Cellular [F2,6BP] depends on the balance between its! rates of synthesis and degradation by PFK-2 ! (phosphofructokinase-2) and FBPase-2 (fructose bisphosphatase-2).! These activities are located on different domains of the! same homodimeric protein (a bifunctional enzyme).! The bifunctional enzyme is regulated by allosteric effectors and by! phosphorylation/dephosphorylation catalyzed by PKA (protein! kinase A) and a phosphoprotein phosphatase.! F2,6BP activates PFK-1 and inhibits FBPase-1. When blood [glucose] is high, cAMP levels decrease, and [F2,6BP]! rises, promoting glycolysis.! The F2,6BP control system in muscle differs from that in liver.! Hormones that stimulate glycogen breakdown in heart muscle lead to phosphorylation of the bifunctional enzyme that stimulates rather than inhibits PFK-2. The increasing [F2,6BP] stimulates glycolysis so that glycogen breakdown and glycolysis are coordinated.! The skeletal muscle PFK-2/PBPase-2 isozyme lacks a phosphorylation! site and is thus not subject to cAMP-dependent control.! Alanine inhibits pyruvate kinase.! Alanine, a major gluconeogenic precursor, inhibits PK.! Liver PK is also inactivated by phosphorylation. Phosphorylation! activates glycogen phosphorylase and FBPase-2: thus the pathways of ! gluconeogenesis and glycogen breakdown both flow towards G6P, ! which is converted to glucose for export from the liver.! Hexokinase/glucokinase and G6Pase activities are also controlled.! Glucose metabolism is regulated by long-term changes in the amounts of enzymes synthesized.! Rates of transcription and mRNA stabilities encoding regulatory enzymes are influenced by hormones. -
Table S6: Differential Expressed Genes Present on KEGG Enrichment Pathways (Ficher Exact Test ≤ 0.05)
Table S6: Differential expressed genes present on KEGG enrichment pathways (Ficher exact test ≤ 0.05). 10 DAP fruit 1) Plant hormone signal transduction ID Gene Name Species Log2 FoldChange Gibberilin 103502508/XP_008464685.1 transcription factor PIF4-like(LOC103502508) Cucumis melo 2.9819 103496794 /XP_008457015.1 DELLA protein GAI-like(LOC103496794) Cucumis melo 2.0955 Auxin 103493078/XP_008451925.1 auxin response factor 18-like(LOC103493078) Cucumis melo 1.3779 103490323/XP_008448013.1 auxin-induced protein 15A-like(LOC103490323) Cucumis melo 6.4446 103489925/XP_008447319.1 auxin-induced protein 22A-like(LOC103489925) Cucumis melo 1.2787 103499752/XP_008461049.1 auxin-induced protein IAA6(LOC103499752) Cucumis melo 1.1910 103489837/XP_008447371.1 auxin-responsive protein IAA11(LOC103489837) Cucumis melo 2.1070 103499461/XP_008460695.1 auxin-responsive protein IAA13(LOC103499461) Cucumis melo 2.6297 /XP_008460694.1 103488149/XP_008444965.1 auxin-responsive protein IAA9-like(LOC103488149) Cucumis melo 1.6545 103493400/XP_008452341.1 indole-3-acetic acid-amido synthetase GH3.6(LOC103493400) Cucumis melo 5.7328 103485860/XP_008441807.1 indole-3-acetic acid-amido synthetase GH3.5-like(LOC103485860) Cucumis melo 3.9427 103490488/XP_008448232.1 indole-3-acetic acid-amido synthetase GH3.6-like(LOC103490488) Cucumis melo 2.5520 Acid Jasmonic 103490781/XP_008448683.1 transcription factor MYC2-like(LOC103490781) Cucumis melo 1.9132 103501422/XP_008463217.1 coronatine-insensitive protein 1(LOC103501422) Cucumis melo 0.6774 Brassinosteroid 103495262/XP_008454979.1 -
Glycogen Metabolism Glycogen Breakdown Glycogen Synthesis
Glycogen Metabolism Glycogen Breakdown Glycogen Synthesis Control of Glycogen Metabolism Glycogen Storage Diseases Glycogen Glycogen - animal storage glucan 100- to 400-Å-diameter cytosolic granules up to 120,000 glucose units α(1 → 6) branches every 8 to 12 residues muscle has 1-2% (max) by weight liver has 10% (max) by weight ~12 hour supply Although metabolism of fat provides more energy: 1. Muscle mobilize glycogen faster than fat 2. Fatty acids of fat cannot be metabolized anaerobically 3. Animals cannot convert fatty acid to glucose (glycerol can be converted to glucose) Glycogen Breakdown Three enzymes: glycogen phosphorylase glycogen debranching enzyme phosphoglucomutase Glycogen phosphorylase (phosphorylase) - phosphorolysis of glucose residues at least 5 units from branch point Glycogen + Pi glycogen + glucose-1-phosphate (n residues) (n-1 residues) homodimer of 842-residues (92-kD) subunits allosteric regulation - inhibitors (ATP, glucose-6- phosphate, glucose) and activator (AMP), T ⇔ R covalent modification (phosphorylation) - modification/demodification 2- phosphorylase a (active, SerOPO3 ) phosphorylase b (less active, Ser) narrow 30-Å crevice binds glycogen, accommodates 4 to 5 residues Pyridoxal-5-phosphate (vit B6 derivative) cofactor - located near active site, general acid-base catalyst Rapid equilibrium Random Bi Bi kinetics Glycogen Breakdown Glycogen debranching enzyme - possesses two activities α(1 → 4) transglycosylase (glycosyl transferase) 90% glycogen → glucose-1-phosphate transfers trisaccharide unit from -
MTOR Signaling and Metabolism in Early T Cell Development
G C A T T A C G G C A T genes Review MTOR Signaling and Metabolism in Early T Cell Development Guy Werlen, Ritika Jain and Estela Jacinto * Department of Biochemistry and Molecular Biology, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ 08854, USA; [email protected] (G.W.); [email protected] (R.J.) * Correspondence: [email protected]; Tel.: +1-732-235-4476 Abstract: The mechanistic target of rapamycin (mTOR) controls cell fate and responses via its func- tions in regulating metabolism. Its role in controlling immunity was unraveled by early studies on the immunosuppressive properties of rapamycin. Recent studies have provided insights on how metabolic reprogramming and mTOR signaling impact peripheral T cell activation and fate. The contribution of mTOR and metabolism during early T-cell development in the thymus is also emerging and is the subject of this review. Two major T lineages with distinct immune functions and peripheral homing organs diverge during early thymic development; the αβ- and γδ-T cells, which are defined by their respective TCR subunits. Thymic T-regulatory cells, which have immunosup- pressive functions, also develop in the thymus from positively selected αβ-T cells. Here, we review recent findings on how the two mTOR protein complexes, mTORC1 and mTORC2, and the signaling molecules involved in the mTOR pathway are involved in thymocyte differentiation. We discuss emerging views on how metabolic remodeling impacts early T cell development and how this can be mediated via mTOR signaling. Keywords: mTOR; mTORC1; mTORC2; thymocytes; T lymphocytes; early T cell development; T-cell metabolism Citation: Werlen, G.; Jain, R.; Jacinto, E. -
12) United States Patent (10
US007635572B2 (12) UnitedO States Patent (10) Patent No.: US 7,635,572 B2 Zhou et al. (45) Date of Patent: Dec. 22, 2009 (54) METHODS FOR CONDUCTING ASSAYS FOR 5,506,121 A 4/1996 Skerra et al. ENZYME ACTIVITY ON PROTEIN 5,510,270 A 4/1996 Fodor et al. MICROARRAYS 5,512,492 A 4/1996 Herron et al. 5,516,635 A 5/1996 Ekins et al. (75) Inventors: Fang X. Zhou, New Haven, CT (US); 5,532,128 A 7/1996 Eggers Barry Schweitzer, Cheshire, CT (US) 5,538,897 A 7/1996 Yates, III et al. s s 5,541,070 A 7/1996 Kauvar (73) Assignee: Life Technologies Corporation, .. S.E. al Carlsbad, CA (US) 5,585,069 A 12/1996 Zanzucchi et al. 5,585,639 A 12/1996 Dorsel et al. (*) Notice: Subject to any disclaimer, the term of this 5,593,838 A 1/1997 Zanzucchi et al. patent is extended or adjusted under 35 5,605,662 A 2f1997 Heller et al. U.S.C. 154(b) by 0 days. 5,620,850 A 4/1997 Bamdad et al. 5,624,711 A 4/1997 Sundberg et al. (21) Appl. No.: 10/865,431 5,627,369 A 5/1997 Vestal et al. 5,629,213 A 5/1997 Kornguth et al. (22) Filed: Jun. 9, 2004 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2005/O118665 A1 Jun. 2, 2005 EP 596421 10, 1993 EP 0619321 12/1994 (51) Int. Cl. EP O664452 7, 1995 CI2O 1/50 (2006.01) EP O818467 1, 1998 (52) U.S. -
An Evolutionary Proteomics Approach for the Identification of Pka
AN EVOLUTIONARY PROTEOMICS APPROACH FOR THE IDENTIFICATION OF PKA TARGETS IN SACCHAROMYCES CEREVISIAE IDENTIFIES ATG1 AND ATG13, TWO PROTEINS THAT PLAY A CENTRAL ROLE IN THE REGULATION OF AUTOPHAGY BY THE RAS/PKA PATHWAY AND THE TOR PATHWAY DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University by Joseph Stephan, MS * * * * * The Ohio State University 2008 Dissertation Committee: Approved by Name: Dr. Paul Herman Name: Dr. Michael Ostrowski _______________________________ Adviser Name: Dr. Mark Parthun Molecular Cellular Developmental Biology Graduate Program Name: Dr. Amanda Simcox ABSTRACT A cell in its natural environment spends most of its time in a quiescent resting state known as G0 in mammals and stationary phase in yeast. A constant challenge the cell faces is then to appropriately determine when the conditions, including nutrient availability, are favorable for it to grow. Since growth involves massive energy expenditure and a vast remodeling of the cell’s genetic program, a correct determination very likely means the difference between survival and death. Therefore, this crucial decision is both very tightly regulated and extensively coordinated in time and space. This coordination involves a synthesis between internal factors, and environmental clues such as the availability of essential nutrients and favorable conditions. The cell typically accomplishes this complex task through the combined actions of multiple signaling pathways. These pathways link cells to the extracellular environment by providing nutrient-sensing and noxious stress information and determining the appropriate response to any given situation through the activation of specific cellular programs. -
A Role for PFK-2/Fbpase-2 As Distinct from Fructose 2,6-Bisphosphate In
A role for PFK-2/FBPase-2 as distinct from fructose 2,6-bisphosphate in regulation of insulin secretion in pancreatic beta-cells Catherine Arden, Laura J Hampson, Guo C Huang, James Am Shaw, Ali Aldibbiat, Graham Holliman, Derek Manas, Salmaan Khan, Alex J Lange, Loranne Agius To cite this version: Catherine Arden, Laura J Hampson, Guo C Huang, James Am Shaw, Ali Aldibbiat, et al.. A role for PFK-2/FBPase-2 as distinct from fructose 2,6-bisphosphate in regulation of insulin secretion in pancre- atic beta-cells. Biochemical Journal, Portland Press, 2008, 411 (1), pp.41-51. 10.1042/BJ20070962. hal-00478850 HAL Id: hal-00478850 https://hal.archives-ouvertes.fr/hal-00478850 Submitted on 30 Apr 2010 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Biochemical Journal Immediate Publication. Published on 26 Nov 2007 as manuscript BJ20070962 Version-2 A role for PFK-2/FBPase-2 as distinct from fructose 2,6-bisphosphate in regulation of insulin secretion in pancreatic beta-cells Catherine Arden*, Laura J. Hampson*, Guo C. Huang*, James A.M. Shaw*, Ali Aldibbiat*, Graham Holliman*, D Manas*, Salmaan Khan#, Alex J. -
Complete Genome Analysis of Gluconacetobacter Xylinus CGMCC
www.nature.com/scientificreports OPEN Complete genome analysis of Gluconacetobacter xylinus CGMCC 2955 for elucidating bacterial Received: 8 November 2017 Accepted: 3 April 2018 cellulose biosynthesis and Published: xx xx xxxx metabolic regulation Miao Liu1, Lingpu Liu1, Shiru Jia1, Siqi Li1, Yang Zou2 & Cheng Zhong1 Complete genome sequence of Gluconacetobacter xylinus CGMCC 2955 for fne control of bacterial cellulose (BC) synthesis is presented here. The genome, at 3,563,314 bp, was found to contain 3,193 predicted genes without gaps. There are four BC synthase operons (bcs), among which only bcsI is structurally complete, comprising bcsA, bcsB, bcsC, and bcsD. Genes encoding key enzymes in glycolytic, pentose phosphate, and BC biosynthetic pathways and in the tricarboxylic acid cycle were identifed. G. xylinus CGMCC 2955 has a complete glycolytic pathway because sequence data analysis revealed that this strain possesses a phosphofructokinase (pf)-encoding gene, which is absent in most BC-producing strains. Furthermore, combined with our previous results, the data on metabolism of various carbon sources (monosaccharide, ethanol, and acetate) and their regulatory mechanism of action on BC production were explained. Regulation of BC synthase (Bcs) is another efective method for precise control of BC biosynthesis, and cyclic diguanylate (c-di-GMP) is the key activator of BcsA–BcsB subunit of Bcs. The quorum sensing (QS) system was found to positively regulate phosphodiesterase, which decomposed c-di-GMP. Thus, in this study, we demonstrated the presence of QS in G. xylinus CGMCC 2955 and proposed a possible regulatory mechanism of QS action on BC production. Bacterial cellulose (BC), naturally produced by several species of Acetobacter, is a strong and ultra-pure form of cellulose1. -
Carbohydrate Kinases: a Conserved Mechanism Across Differing Folds
catalysts Review Carbohydrate Kinases: A Conserved Mechanism Across Differing Folds Sumita Roy 1, Mirella Vivoli Vega 2 and Nicholas J. Harmer 1,* 1 Living Systems Institute, University of Exeter, Stocker Road, Exeter EX4 4QD, UK; [email protected] 2 Department of Biomedical Experimental and Clinical Sciences, University of Florence, Viale Morgagni 50, 50134 Florence, Italy; mirella.vivoli@unifi.it * Correspondence: [email protected]; Tel.: +44-1392-725179 Received: 2 November 2018; Accepted: 21 December 2018; Published: 2 January 2019 Abstract: Carbohydrate kinases activate a wide variety of monosaccharides by adding a phosphate group, usually from ATP. This modification is fundamental to saccharide utilization, and it is likely a very ancient reaction. Modern organisms contain carbohydrate kinases from at least five main protein families. These range from the highly specialized inositol kinases, to the ribokinases and galactokinases, which belong to families that phosphorylate a wide range of substrates. The carbohydrate kinases utilize a common strategy to drive the reaction between the sugar hydroxyl and the donor phosphate. Each sugar is held in position by a network of hydrogen bonds to the non-reactive hydroxyls (and other functional groups). The reactive hydroxyl is deprotonated, usually by an aspartic acid side chain acting as a catalytic base. The deprotonated hydroxyl then attacks the donor phosphate. The resulting pentacoordinate transition state is stabilized by an adjacent divalent cation, and sometimes by a positively charged protein side chain or the presence of an anion hole. Many carbohydrate kinases are allosterically regulated using a wide variety of strategies, due to their roles at critical control points in carbohydrate metabolism.